Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Gallicano

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|September 1, 1994
Effect of bismuth subsalicylate on ciprofloxacin bioavailabilityL Rambout, J Sahai, K Gallicano, et al.
AIDS (London, England)|September 21, 2000
Acute monoarthritis complicating therapy with indinavirJ I Brooks, K Gallicano, G Garber, et al.
Annals of Internal Medicine|October 15, 1995
Effects of the antacids in didanosine tablets on dapsone pharmacokineticsJ Sahai, G Garber, K Gallicano, et al.
AIDS (London, England)|June 1, 1994
Relationship between body weight, body surface area and serum zidovudine pharmacokinetic parameters in adult, male HIV-infected patientsJ Sahai, K Gallicano, E Ormsby, et al.
Clinical Pharmacology and Therapeutics|February 17, 2001
Effect of ketoconazole on ritonavir and saquinavir concentrations in plasma and cerebrospinal fluid from patients infected with human immunodeficiency virusY Khaliq, K Gallicano, S Venance, et al.
British Journal of Clinical Pharmacology|June 26, 2001
Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteersY Khaliq, K Gallicano, C Tisdale, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 2003
A review of low-dose ritonavir in protease inhibitor combination therapyC L Cooper, R P G van Heeswijk, K Gallicano, et al.
AIDS (London, England)|March 29, 2001
An argument for routine therapeutic drug monitoring of HIV-1 protease inhibitors during pregnancyJ B Angel, Y Khaliq, M L Monpetit, et al.
Clinical Pharmacology and Therapeutics|August 15, 2001
A pharmacokinetic study of intermittent rifabutin dosing with a combination of ritonavir and saquinavir in patients infected with human immunodeficiency virusK Gallicano, Y Khaliq, G Carignan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 1995
Effect of rifabutin on the pharmacokinetics of zidovudine in patients infected with human immunodeficiency virusK Gallicano, J Sahai, L Swick, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|September 1, 1994
Effect of bismuth subsalicylate on ciprofloxacin bioavailabilityL Rambout, J Sahai, K Gallicano, et al.
AIDS (London, England)|September 21, 2000
Acute monoarthritis complicating therapy with indinavirJ I Brooks, K Gallicano, G Garber, et al.
Annals of Internal Medicine|October 15, 1995
Effects of the antacids in didanosine tablets on dapsone pharmacokineticsJ Sahai, G Garber, K Gallicano, et al.
AIDS (London, England)|June 1, 1994
Relationship between body weight, body surface area and serum zidovudine pharmacokinetic parameters in adult, male HIV-infected patientsJ Sahai, K Gallicano, E Ormsby, et al.
Clinical Pharmacology and Therapeutics|February 17, 2001
Effect of ketoconazole on ritonavir and saquinavir concentrations in plasma and cerebrospinal fluid from patients infected with human immunodeficiency virusY Khaliq, K Gallicano, S Venance, et al.
British Journal of Clinical Pharmacology|June 26, 2001
Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteersY Khaliq, K Gallicano, C Tisdale, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 2003
A review of low-dose ritonavir in protease inhibitor combination therapyC L Cooper, R P G van Heeswijk, K Gallicano, et al.
AIDS (London, England)|March 29, 2001
An argument for routine therapeutic drug monitoring of HIV-1 protease inhibitors during pregnancyJ B Angel, Y Khaliq, M L Monpetit, et al.
Clinical Pharmacology and Therapeutics|August 15, 2001
A pharmacokinetic study of intermittent rifabutin dosing with a combination of ritonavir and saquinavir in patients infected with human immunodeficiency virusK Gallicano, Y Khaliq, G Carignan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 1995
Effect of rifabutin on the pharmacokinetics of zidovudine in patients infected with human immunodeficiency virusK Gallicano, J Sahai, L Swick, et al.
Pageof 4